+319.7%
MRNA vs ADVB
-89.8%
+409.5%
-37.8%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 10y.
| Period | Portfolio | ADVB | Excess | Alpha |
|---|---|---|---|---|
| 1D | +5.4% | -7.5% | +12.8% | +5.4% |
| 7D | -1.1% | -12.3% | +11.2% | -1.0% |
| 30D | +126.1% | +7.8% | +118.4% | +125.5% |
| 3M | +190.0% | +104.2% | +85.8% | +170.7% |
| 6M | +157.2% | +58.1% | +99.1% | +137.8% |
| YTD | +388.2% | +40.2% | +348.0% | +352.2% |
| 1Y | +467.0% | -16.1% | +483.1% | +444.8% |
| All | +319.7% | -89.8% | +409.5% | +347.1% |
Cumulative growth
Daily Returns
Daily percentage return beside ADVB.
Daily Out/Under-Performance
Portfolio return minus ADVB return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × ADVB return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 10y: compounded portfolio wealth divided by compounded ADVB wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
10y analysis · Full analysis span regression · 6 months rolling